By Editor , 25 September 2026

Shanghai – September 25, 2026 -- Nutshell Therapeutics (Shanghai) Co., Ltd. has received FDA clearance of its Investigational New Drug (IND) application for NTS231, a covalent allosteric molecular glue degrader targeting NRF2, allowing the company to begin clinical development in the United States. NTS231 is the first NRF2 degrader originating from China and only the second such molecule worldwide to reach clinical-stage development.

By Editor , 25 September 2026
Ault & Company Holds 62% of Hyperscale Data, Cites Valuation Gap

Las Vegas – September 25, 2026 -- Ault & Company, Inc. has invested $55 million directly into Hyperscale Data, Inc. through convertible preferred stock purchases, building a beneficial ownership stake of approximately 62% in the NYSE American-listed company.

By Editor , 25 September 2026

Beijing – September 25, 2026 -- Yiren Digital Ltd. (NYSE: YRD) will release unaudited financial results for the second quarter ended June 30, 2026, before U.S. markets open on Wednesday, September 30, 2026.

By Editor , 25 September 2026
Sterling Contract Packaging Featured on Public TV for Integrated Healthcare Packaging Model

South Carolina -- A new Public Television segment filmed on May 6, 2026, at Sterling Contract Packaging's South Carolina facility examines how consolidating packaging design, engineering, and manufacturing under one operator is reshaping healthcare product distribution. The feature, part of the nationally syndicated "All Access hosted by Andy Garcia" series, positions single-source packaging models as an alternative to fragmented, multi-vendor supply chains that have historically caused delays and compliance failures in the medical device and OTC pharmaceutical sectors.

By Editor , 25 September 2026

Copenhagen – September 25, 2026 -- H. Lundbeck A/S will relocate its US headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts, establishing a global innovation hub in the region over the next year.

By Editor , 25 September 2026
Nauticus Robotics Signs LOI for Up to $50M Equity Investment

Houston – September 25, 2026 -- Nauticus Robotics (NASDAQ: KITT) has entered into a non-binding letter of intent with a strategic investor for a private placement equity investment of up to $50 million.

Strategic investor eyes up to $50 million stake in Nauticus Robotics

The autonomous subsea robotics developer disclosed the LOI on Sept. 25, 2026, framing the potential capital injection as support for its short- and long-term commercial objectives. The deal remains non-binding and does not obligate the investor to fund the transaction.

By Editor , 25 September 2026
Xi Pledges 100,000 US Youth Exchanges as China-US Trade Ties Deepen

Beijing -- Chinese President Xi Jinping announced on September 24, 2026 that China will invite 100,000 young Americans for exchange and study programs over the next five years, a pledge made during a White House welcome ceremony marking his state visit to the United States.

By Editor , 25 September 2026
Pacsun Report: Gen Z Trusts Family Over Influencers, AI

Los Angeles – September 24, 2026 -- Young consumers trust artificial intelligence for everyday use but not for advice, according to a new industry report that has reshaped how retail and consumer brands are approaching Gen Z engagement.

By Editor , 25 September 2026
XtalPi Files FDA IND for First Gut-Restricted Pan-TRK Pain Drug

Boston and Shenzhen – September 24, 2026 -- XtalPi Holdings Limited (HKEX: 2228) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for KQTD-126, a potential first-in-class gut-restricted pan-tropomyosin receptor kinase (pan-TRK) inhibitor targeting chronic intestinal pain in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).